Clinical Trials List
2014-03-31 - 2022-12-31
Phase III
Terminated5
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Wei-Wu Chen Division of Hematology & Oncology
- 林季宏 Division of Hematology & Oncology
- YEN-SHEN LU Division of Hematology & Oncology
- MING-YANG WANG Division of General Surgery
- 張端瑩 Division of Hematology & Oncology
- 郭文宏 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Wen-Chi Shen Division of Hematology & Oncology
- 沈士哲 Division of General Surgery
- 張潤忠 Division of Radiology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 金光亮 無
- Yi-Fang Tsai 無
- Ta-Chung Chao 無
- 邱仁輝 無
- Chun-Yu Liu 無
- Jane Wang 無
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Wei-Hwa Lee 無
- 蘇勇誠 無
- CHIH-MING SU 未分科
- Tsu-Yi Chao 無
- Wei-Hong Cheng 無
- Yao-Yu Hsieh 無
- 蘇智銘 無
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chieh-Han Chuang 無
- Fu Ouyang 未分科
- Jui-Sheng Hsu 無
- Fang-Ming Chen 無
- 甘蓉瑜 無
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
19 participants
-
Global
668 participants
